Hyperspectral Imaging Systems Market worth $21.33 Billion by 2023

-

According to research report the global hyperspectral imaging systems market is projected to reach USD 21.33 billion by 2023 from USD 9.51 billion in 2018, at a CAGR of 17.5%. The growing industrial applications of hyperspectral imaging and increasing funding & investments are the major factors driving the growth of the hyperspectral imaging systems market.
Product launches accounted for the largest share of the overall growth strategies followed by key players between 2015 and 2018. Some of the companies that adopted this strategy include Headwall Photonics (US), SPECIM (Finland), Telops (Canada), Applied Spectral Imaging (US), and ChemImage Corporation (US).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=246979343
The hyperspectral imaging systems market comprises several large as well as small players. The prominent players in this market include Headwall Photonics (US), Corning Incorporated (US), SPECIM (Finland), Resonon (US), Telops (Canada), Norsk Elektro Optikk (Norway), Applied Spectral Imaging (US), BaySpec (US), Surface Optics Corporation (US), Cubert (Germany), and ChemImage Corporation (US).
Headwall Photonics (US) manufactures and provides optical modules and fully-integrated imaging instruments with original holographic diffraction gratings. The company offers products for industrial inspection, defense and security, remote sensing, and research applications. The company pursues the strategies of product launches and expansions to widen its sales and distribution network. For instance, in February 2016, Headwall introduced HyperCore, a new, powerful data processing product that is specially designed for UAV airborne applications requiring sensor fusion. To expand its engineering, sales, and marketing capabilities to meet the increasing demand for its spectral imaging solutions, the company opened a new facility in Boston (US) in 2017.
SPECIM (Finland) is a leading manufacturer of hyperspectral imaging instruments and systems. The company provides hyperspectral imaging products to a number of industrial OEM customers and research organizations. It pursues the strategy of product launches to strengthen its portfolio and increase its share in the market. In the last three years, the company has launched various products to widen its consumer base. SPECIM is consistently looking to improve its global distribution network; for example, in April 2017, the company signed agreements with three companies, namely, Tech Imaging Services, Line Associates, and DATVISION to strengthen its distribution network in the US and South Korea.
Get Report Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=246979343
Norsk Elektro Optics (Norway) is a research-oriented company in the electro-optical instrumentation segment. The company manufactures advanced electro-optical products using an in-house technology for the international market. It also participates in a number of international R&D projects in the electro-optical field. The company’s growth strategies include being involved in research projects to strengthen its product portfolio and promoting the adoption of its technologies. In view of the changing trends in the hyperspectral imaging systems market, the company focuses on collaborating in R&D projects with key research institutes, the projects include most application areas where hyperspectral imaging is applicable, e.g. mining, food inspection, search and rescue, cultural heritage and restoration, precision farming, medical applications, and many others.

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more